ZIPRASIDONE        SUPPORTING DATA 
Supporting data
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
print this page
 Guidelines

Strengths:

Proven efficacy in the acute treatment of mania

  • In a 3-week study of bipolar patients currently experiencing a manic or mixed episode, ziprasidone-treated patients showed substantial improvement as early as 2 days into the study and maintained that improvement until the study end. [ICG Guidelines]
  • Following remission of an initial episode of mania, patients should be withdrawn from their benzodiazepine or antipsychotic once the acute episode has resolved. [Australian Guidelines]

Weaknesses:

Data on maintenance are limited

  • Following remission of an initial episode of mania, patients should be withdrawn from their benzodiazepine or antipsychotic once the acute episode has resolved. [Australian Guidelines]
International Consensus Group on Bipolar I Depression


 
  
home help sitemap acronyms help sitemap home